• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏刺激的未来:生理性还是无导线起搏?

Bridging the future of cardiac stimulation: physiologic or leadless pacing?

机构信息

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

出版信息

Rev Cardiovasc Med. 2022 Mar 17;23(3):107. doi: 10.31083/j.rcm2303107.

DOI:10.31083/j.rcm2303107
PMID:35345274
Abstract

Cardiac simulation has moved from early life-saving pacemakers meant only to prevent asystole to current devices capable of physiologic stimulation for the treatment of heart rhythm and heart failure, that are also intended for remote patient and disease-progression monitoring. The actual vision of contemporary pacing aims to correct the electrophysiologic roots of mechanical inefficiency regardless of underlying structural heart diseases. The awareness of the residual cardiac dyssynchrony related to customary cardiac pacing has changed the concept of what truly represents "physiologic pacing". On a different perspective, leadless stimulation to abolish CIED surgery and prevent lead-related complications is becoming a priority both for young device recipients and for frail, elderly patients. Careful clinical evaluation attempts to bridge decision-making to patient-tailored therapy.

摘要

心脏模拟已经从早期仅用于防止停搏的救生起搏器发展到目前能够进行生理刺激以治疗心律失常和心力衰竭的设备,这些设备也旨在用于远程患者和疾病进展监测。当代起搏的实际目标是纠正机械效率低下的电生理根源,而不管潜在的结构性心脏病如何。对与常规心脏起搏相关的残余心脏不同步的认识改变了真正代表“生理起搏”的概念。从另一个角度来看,无导线刺激以消除 CIED 手术并预防与导线相关的并发症,这对于年轻的设备接受者和体弱的老年患者来说都变得至关重要。仔细的临床评估试图将决策与患者个体化治疗联系起来。

相似文献

1
Bridging the future of cardiac stimulation: physiologic or leadless pacing?心脏刺激的未来:生理性还是无导线起搏?
Rev Cardiovasc Med. 2022 Mar 17;23(3):107. doi: 10.31083/j.rcm2303107.
2
Pacing devices to treat bradycardia: current status and future perspectives.起搏设备治疗心动过缓:现状和未来展望。
Expert Rev Med Devices. 2021 Feb;18(2):161-177. doi: 10.1080/17434440.2021.1866543. Epub 2020 Dec 31.
3
Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.心脏起搏器的进展与未来方向:系列文章第 2 部分。
J Am Coll Cardiol. 2017 Jan 17;69(2):211-235. doi: 10.1016/j.jacc.2016.10.064.
4
Leadless Pacemakers: State of the Art and Future Perspectives.无导线起搏器:现状与未来展望。
Card Electrophysiol Clin. 2018 Mar;10(1):17-29. doi: 10.1016/j.ccep.2017.11.003.
5
First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients.首例无导线超声心脏起搏系统植入:心力衰竭患者的新型心内膜左心室再同步治疗。
Europace. 2013 Aug;15(8):1191-7. doi: 10.1093/europace/eut124. Epub 2013 May 23.
6
Cardiac pacing and lead devices management: 25 years of research at EP Europace journal.心脏起搏和导联设备管理:EP Europace 杂志 25 年的研究成果。
Europace. 2023 Aug 25;25(8). doi: 10.1093/europace/euad202.
7
Leadless Cardiac Pacemakers: The Next Evolution in Pacemaker Technology.无导线心脏起搏器:起搏器技术的下一次演进
R I Med J (2013). 2017 Nov 1;100(11):31-34.
8
Leadless pacemaker implantation after lead extraction for cardiac implanted electronic device infection.经心脏植入式电子设备感染的导线拔除术后行无导线起搏器植入。
J Cardiovasc Electrophysiol. 2022 Mar;33(3):464-470. doi: 10.1111/jce.15363. Epub 2022 Jan 31.
9
In the wireless era: leadless pacing.在无线时代:无导线起搏。
Expert Rev Cardiovasc Ther. 2010 Feb;8(2):171-4. doi: 10.1586/erc.09.168.
10
Permanent Leadless Cardiac Pacemaker Therapy: A Comprehensive Review.无导线心脏起搏器永久治疗:全面综述。
Circulation. 2017 Apr 11;135(15):1458-1470. doi: 10.1161/CIRCULATIONAHA.116.025037.

引用本文的文献

1
Leadless Pacemaker Implantation in the Emergency Bradyarrhythmia Setting: Results from a Multicenter European Registry.无导线起搏器在紧急缓慢性心律失常患者中的植入:来自多中心欧洲注册研究的结果。
Medicina (Kaunas). 2022 Dec 28;59(1):67. doi: 10.3390/medicina59010067.